|
|
Other links at Articles > Business of Medicine |
| 4. |
Rituxan Linked to Fatal PML Case
|
|
|
Clinicians advised to consider PML in rituximab-treated patients presenting with new-onset neurologic manifestations. Medscape Medical News
|
| 5. |
More Action Possible Erythropoiesis-Stimulating Agents: US FDA
|
|
|
U.S. regulators said on Thursday they were reviewing two recent studies that provided more evidence of serious risks for some cancer patients treated with erythropoiesis-stimulating agents, also known as ESAs or Epo drugs, for anemia. Reuters Health Information
|
|
|